Accurate, sourced perspectives on Korean medicine — for American patients and professionals who want to understand what the data actually shows.
Korea's treatable mortality rate is 43 per 100,000 — nearly half the OECD average of 79. Last year, over 600,000 international patients chose Korean hospitals. Most Americans have no idea this is happening. Here's what the data shows, and why it matters.
Read Article
According to CONCORD-3 — the largest global cancer survival study ever conducted — Korea's 5-year stomach cancer survival rate is 69%. Colorectal cancer: 72%. These numbers come from peer-reviewed science. They deserve to be part of your decision.
Read ArticleProcedures at JCI-accredited Korean hospitals cost 30–70% less than their US equivalents — with English-speaking staff, shorter waits, and outcomes data that speaks for itself. Here's the full picture, in plain numbers.
Read ArticleIn 2025, South Korea treated more than 2 million international patients for the first time in its history. American patient volume jumped 70.4% in a single year. Here is what the data tells us about why.
Read ArticleA full-body health screening in the US can take months to schedule and cost thousands of dollars. In Seoul, it takes one to two days — with results that are often more comprehensive than anything available at home.
Read ArticleStem cell therapy is one of the fastest-growing treatments in Korean medicine. American patients are traveling to Seoul for applications in orthopedics, neurology, and anti-aging that are either unavailable or prohibitively expensive in the US.
Read ArticleIn Newsweek's 2026 ranking of the world's best specialized hospitals, Korean institutions placed among the global leaders for cancer treatment. Most Americans have never heard of them.
Read ArticleGetting treatment in Korea is more accessible than most Americans expect. Incheon Airport connects to dozens of US cities. Major hospitals have English-speaking international centers. Here is the full step-by-step process.
Read ArticleOf the 2 million international patients who visited Korea in 2025, 1.3 million came for dermatology — the single largest specialty category, growing at 86.2% year-over-year. This is no longer a beauty trend. It is a medical migration.
Read ArticleAmerican patients are flying to Seoul for aesthetic treatments at a fraction of US prices — administered by board-certified dermatologists with access to technology that may not yet be available in the US.
Read ArticleThe average wait to see a US dermatologist is 36 days. In Seoul, same-week appointments at physician-run clinics are routine. The differences between Korean and US dermatology go much deeper than scheduling.
Read ArticleSouth Korea performs more plastic surgery per capita than anywhere else in the world. In 2025, over 220,000 international patients came for cosmetic procedures. Here is what American patients considering Korean plastic surgery actually need to know.
Read ArticleV-line jaw reduction is one of the most searched Korean cosmetic procedures among international patients. It is also one of the most technically demanding. Here is an honest guide to what the procedure involves and what recovery looks like.
Read ArticleKorea is at the frontier of anti-aging medicine — combining energy-based devices, injectables, and regenerative biologics that are either unavailable or prohibitively expensive in the US. Here is what 2026 Korean anti-aging treatment looks like.
Read ArticleA knee replacement in the US averages $30,000–$50,000 out of pocket. In Korea, the same procedure at a JCI-accredited hospital costs significantly less — with outcomes data that competes with the best American centers.
Read ArticleKorea's prostate cancer 5-year survival rate is 96.9%. Breast cancer: 94.7%. These numbers are not only competitive with the US — in some categories, they exceed it. Here is what American cancer patients should know about Korean oncology.
Read Article173,000 American patients chose Korean hospitals in 2025 — a 70.4% increase in a single year. They came for cancer care, dermatology, plastic surgery, orthopedics, and comprehensive health screenings. Here is what they found.
Read ArticleMedical and statistical information on this site is sourced from peer-reviewed research and recognized organizations including OECD, CONCORD-3 (The Lancet), Korea Health Industry Development Institute (KHIDI), and the Korean National Cancer Information Center. Content is provided for informational purposes only and does not constitute medical advice. Individual outcomes vary. KoreMed Consulting Group, Inc. is a marketing and consulting agency, not a licensed medical provider.